Viralytics Ltd (OTCQX International:VRACY.PK)

Data as of Jan 27
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Viralytics Ltd. is a biotechnology company. The company focuses on the development of oncolytic virotherapy for the treatment of cancers. Its products include CAVATAK™ and EVATAK™. The company was founded on August 14, 1986 and is headquartered in Sydney, Australia.

Contact Information

Viralytics Ltd.
66 Hunter Street
Sydney New South Wales (nsw) 2000
P:(129) 988-4000
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Malcolm L. McCollChief Executive Officer
Robert C. VickeryChief Financial Officer
Darren ShafrenChief Scientific Officer
Sarah PrinceSecretary

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.